JAMA Psychiatry

Article	Citations
Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm?	616
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder	603
Establishment of Best Practices for Evidence for Prediction	395
Internet-Based Cognitive Behavioral Therapy for Depression	389
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	374
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness	336
Prevention of Psychosis	276
How COVID-19 Affects the Brain	274
Perturbations in Gut Microbiota Composition in Psychiatric Disorders	266
Association Between Physical Activity and Risk of Depression	253
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence	237
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19	234
Battling the Modern Behavioral Epidemic of Loneliness	218
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia	202
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	197
From Basic Science to Clinical Application of Polygenic Risk Scores	185
Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis	161
Could Polygenic Risk Scores Be Useful in Psychiatry?	156
Mental Health in the Coronavirus Disease 2019 Emergency—The Italian Response	156
Psychosocial Interventions and Immune System Function	152
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	147
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries	147
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes	145
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder	144
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection	142

Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	142
Telepsychiatry and the Coronavirus Disease 2019 Pandemic—Current and Future Outcomes of the Rapid Virtualization of Psychiatric Care	141
Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms	141
Probability of Transition to Psychosis in Individuals at Clinical High Risk	140
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions	135
Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders	133
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder	131
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	125
Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression	122
Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse	118
Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression	116
The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health	116
Cognitive Behavioral Treatments for Anxiety in Children With Autism Spectrum Disorder	115
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders	114
Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 Pandemic	114
The Current Status of Psychedelics in Psychiatry	114
Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries	112
Adjunctive Psychotherapy for Bipolar Disorder	109
Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings	107
Association of Outdoor Artificial Light at Night With Mental Disorders and Sleep Patterns Among US Adolescents	105
Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women	101
Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic	100
Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders	99
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder	98
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia	98
Effect of Zuranolone vs Placebo in Postpartum Depression	97
Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell–Derived Cerebral Organoids in Schizophrenia	97
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	95
Racial Differences in Statewide Suicide Mortality Trends in Maryland During the Coronavirus Disease 2019 (COVID-19) Pandemic	95
Male and Female Physician Suicidality	93
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis	92
Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients	92
Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth	92
Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence	91
Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers	91
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders	90
Joint International Collaboration to Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic	89
Etiology of Autism Spectrum Disorders and Autistic Traits Over Time	87
The Genetic Architecture of Depression in Individuals of East Asian Ancestry	85
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure	85
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses	83
Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders	82
Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain	81
National Trends in Mental Health Care for US Adolescents	81
Association of Preeclampsia in Term Births With Neurodevelopmental Disorders in Offspring	81
Association of Patient Treatment Preference With Dropout and Clinical Outcomes in Adult Psychosocial Mental Health Interventions	81
Association of Cannabis Use During Adolescence With Neurodevelopment	79
Association of Drug Cues and Craving With Drug Use and Relapse	76
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	76
Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder	76

Risk of Subjection to Violence and Perpetration of Violence in Persons With Psychiatric Disorders in Sweden	76
Social Isolation and Loneliness in Older Adults—A Mental Health/Public Health Challenge	74
All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids	74
Clinical Validity ofDSM-5Attenuated Psychosis Syndrome	74
Suicide Prevention in the COVID-19 Era	73
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity	73
Applying Causal Inference Methods in Psychiatric Epidemiology	73
Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men	72
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis	71
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic	69
Association of Mental Disorder in Childhood and Adolescence With Subsequent Educational Achievement	69
Prediction, Not Association, Paves the Road to Precision Medicine	69
Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons	68
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level	68
Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms	68
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features	67
Effectiveness of Task-Shifted Trauma-Focused Cognitive Behavioral Therapy for Children Who Experienced Parental Death and Posttraumatic Stress in Kenya and Tanzania	67
Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning	66
Emergency Department Encounters Among Youth With Suicidal Thoughts or Behaviors During the COVID-19 Pandemic	65
Efficacy and Safety of Lumateperone for Treatment of Schizophrenia	64
Association of US Nurse and Physician Occupation With Risk of Suicide	64
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019	64
Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment	64
Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety	63
Association Between Ambient Heat and Risk of Emergency Department Visits for Mental Health Among US Adults, 2010 to 2019	61
Contingency Management for Patients Receiving Medication for Opioid Use Disorder	61
Associations Between Depression, Arterial Stiffness, and Metabolic Syndrome Among Adults in the UK Biobank Population Study	60
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia	59
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic	59
Stratified Care vs Stepped Care for Depression	58
Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children	58
Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities	57
Association of Screen Time With Internalizing and Externalizing Behavior Problems in Children 12 Years or Younger	57
Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?	56
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia	55
Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects	54
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence	54
Genetic Associations Between Childhood Psychopathology and Adult Depression and Associated Traits in 42 998 Individuals	53
Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia	53
Association of Antihypertensive Drug Target Genes With Psychiatric Disorders	52
Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder	52
Multimodal Categorical and Dimensional Approaches to Understanding Threat Conditioning and Its Extinction in Individuals With Anxiety Disorders	52
Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder	52
Association of Hypothyroidism and Clinical Depression	51
Outcomes of Randomized Clinical Trials of Interventions to Enhance Social, Emotional, and Spiritual Components of Wisdom	51
Computational Mechanisms of Effort and Reward Decisions in Patients With Depression and Their Association With Relapse After Antidepressant Discontinuation	50
Management of Patients With Severe Mental Illness During the Coronavirus Disease 2019 Pandemic	50
Trends in Suicidality 1 Year Before and After Birth Among Commercially Insured Childbearing Individuals in the United States, 2006-2017	49
Meeting Maternal Mental Health Needs During the COVID-19 Pandemic	49
Reinforcement Learning in Patients With Mood and Anxiety Disorders vs Control Individuals	49
Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness	49
Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment	49
Association of Schizophrenia Spectrum Disorders and Violence Perpetration in Adults and Adolescents From 15 Countries	48
A Development Pathway Towards Precision Mental Health Care	48
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People	47
Racial/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic	47
Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder	47
Suicide Prevention Research Priorities in Health Care	47
Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder	46
Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US	46
Preaddiction—A Missing Concept for Treating Substance Use Disorders	46
Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder	45
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	45
Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function	45
Can Sophisticated Study Designs With Regression Analyses of Observational Data Provide Causal Inferences?	45
Longitudinal Associations of Mental Disorders With Dementia	44
Trends in the Incidence and Lethality of Suicidal Acts in the United States, 2006 to 2015	44
Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder	44
Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population	44
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma	44
Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits	43
Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non–COVID-19 Illness	43
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	43
Reinforcement Learning Disruptions in Individuals With Depression and Sensitivity to Symptom Change Following Cognitive Behavioral Therapy	43
Cost-effectiveness of Treatments for Opioid Use Disorder	43
Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails	43
Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition	43
Implementation and Effectiveness of Nonspecialist-Delivered Interventions for Perinatal Mental Health in High-Income Countries	42
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	42
Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness	42

Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals	42
Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression	42
Religious Service Attendance and Deaths Related to Drugs, Alcohol, and Suicide Among US Health Care Professionals	42
Treatment of Patients With Anorexia Nervosa in the US—A Crisis in Care	42
Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark	41
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia	41
The Healthy Brain and Child Development Study—Shedding Light on Opioid Exposure, COVID-19, and Health Disparities	41
Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder	40
Association of Maternal Eating Disorders With Pregnancy and Neonatal Outcomes	40
Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis	40
The Loss of Social Connectedness as a Major Contributor to Physician Burnout	40
Prevalence and Trends in Suicidal Behavior Among US Military Veterans During the COVID-19 Pandemic	40
Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia	39
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode	39
Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis	39
Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia	39
The Differential Outcomes of Coronavirus Disease 2019 in Low- and Middle-Income Countries vs High-Income Countries	39
An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings	39
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression	39
Going Upstream to Advance Psychosis Prevention and Improve Public Health	39
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	39
Current Epidemiological Trends in Firearm Mortality in the United States	38
Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults	38
Association of Multigenerational Family History of Depression With Lifetime Depressive and Other Psychiatric Disorders in Children	38
Preparing for the Bursting of the Psychedelic Hype Bubble	38
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	38
Risk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia	38
Assessment of Neurobiological Mechanisms of Cortical Thinning During Childhood and Adolescence and Their Implications for Psychiatric Disorders	38
Use of Medications for Alcohol Use Disorder in the US	37
Removing the Reliability Bottleneck in Functional Magnetic Resonance Imaging Research to Achieve Clinical Utility	37
Why Deaths of Despair Are Increasing in the US and Not Other Industrial Nations—Insights From Neuroscience and Anthropology	37
Computational Markers of Risky Decision-making for Identification of Temporal Windows of Vulnerability to Opioid Use in a Real-world Clinical Setting	37
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	37
Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample	37
Association of Intrinsic Brain Architecture With Changes in Attentional and Mood Symptoms During Development	37
Association of High Traditional Masculinity and Risk of Suicide Death	37
Association of Nondiscrimination Policies With Mental Health Among Gender Minority Individuals	36
Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US	36
Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder	36
Mortality Associated With Mental Disorders and Comorbid General Medical Conditions	35
Mood Homeostasis Before and During the Coronavirus Disease 2019 (COVID-19) Lockdown Among Students in the Netherlands	35
Driving Performance and Cannabis Users’ Perception of Safety	35
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders	35
Novel Risk Loci Associated With Genetic Risk for Bipolar Disorder Among Han Chinese Individuals	35
Association of History of Psychopathology With Accelerated Aging at Midlife	35
Race as a Social Construct in Psychiatry Research and Practice	35
Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients	35
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	35
Association of Social Determinants of Health and Vaccinations With Child Mental Health During the COVID-19 Pandemic in the US	34
A Framework for Advancing Precision Medicine in Clinical Trials for Mental Disorders	34
Effectiveness of a Guided Web-Based Self-help Intervention to Prevent Depression in Patients With Persistent Back Pain	33
Discriminating Heterogeneous Trajectories of Resilience and Depression After Major Life Stressors Using Polygenic Scores	33
Effect of Shamiri Layperson-Provided Intervention vs Study Skills Control Intervention for Depression and Anxiety Symptoms in Adolescents in Kenya	33
Association of Youth Depression With Subsequent Somatic Diseases and Premature Death	33
Risk of Early-Onset Depression Associated With Polygenic Liability, Parental Psychiatric History, and Socioeconomic Status	33
Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder	33
Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder	33
Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated With SARS-CoV-2 Infection	32
Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US	32
Changes Over Time in the Differential Mortality Gap in Individuals With Mental Disorders	32
Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals	32
Clinical Genetic Testing in Autism Spectrum Disorder in a Large Community-Based Population Sample	31
Changes and Inequities in Adult Mental Health–Related Emergency Department Visits During the COVID-19 Pandemic in the US	31
Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States	31
Psychiatry in Times of the Coronavirus Disease 2019 (COVID-19) Pandemic	31
Structural Magnetic Resonance Imaging All Over Again	31
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	31
Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression	31
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	30
Effect of Online 1-Day Cognitive Behavioral Therapy–Based Workshops Plus Usual Care vs Usual Care Alone for Postpartum Depression	30
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth	30
National Trends of Mental Health Care Among US Adults Who Attempted Suicide in the Past 12 Months	30
Comparison of Genetic Liability for Sleep Traits Among Individuals With Bipolar Disorder I or II and Control Participants	30
Time to Support Extensive Implementation of Shared Decision Making in Psychiatry	30
Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19	30
Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder	30
Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia	30
Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care	29
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span	29
Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation	29
Socioeconomic Indicators of Treatment Prognosis for Adults With Depression	29
Pragmatic Precision Psychiatry—A New Direction for Optimizing Treatment Selection	29
Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count	29
Association of Borderline Personality Disorder Criteria With Suicide Attempts	29
Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia	29
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	29
Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems	28
Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy	28
Association of Early-Life Mental Health With Biomarkers in Midlife and Premature Mortality	27
Association of Magnetoencephalographically Measured High-Frequency Oscillations in Visual Cortex With Circuit Dysfunctions in Local and Large-scale Networks During Emerging Psychosis	27
Tapering Antipsychotic Treatment	27
Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data	26
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19	26
Mood Homeostasis, Low Mood, and History of Depression in 2 Large Population Samples	26
The Origin of Our Modern Concept of Depression—The History of Melancholia From 1780-1880	26